OrbusNeich FY26 H1 profit attributable to owners rises 9% to US$21.57 million; revenue climbs 18.1% to US$98.71 million

• OrbusNeich posted 1H 2026 revenue of US$98.71 million, up 18.1%, while profit attributable to owners rose 9% to US$21.57 million.
• Basic earnings per share increased to 2.62 US cents from a year earlier; gross profit margin widened 1.6 percentage points to 68.5%.
• Finance income net slipped to US$3.34 million from a year earlier, on lower fixed deposit balances and lower interest rates.
• APAC revenue climbed 24.5% to US$34.01 million; EMEA rose 16.7% to US$26.15 million, helped by stronger Europe direct sales.
• Board declared an interim dividend of HK8 cents per share; cash and bank balances stood at about US$224.3 million at June 30.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrbusNeich Medical Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260907-12322854), on September 07, 2026, and is solely responsible for the information contained therein.